You are here

  • Home
  • Archive
  • Volume 70, Issue 9
  • Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study

Article metrics

Article menu
Clinical and epidemiological research
Extended report
Mavrilimumab, a human monoclonal antibody targeting GM-CSF receptor-α, in subjects with rheumatoid arthritis: a randomised, double-blind, placebo-controlled, phase I, first-in-human study

 

Online download statistics by month:

Online download statistics by month: May 2011 to March 2024

AbstractFullPdf
May 20111066480
Jun 2011151235192
Jul 2011199104153
Aug 2011430148301
Sep 201118465127
Oct 20111535362
Nov 2011864777
Dec 2011967079
Jan 20121776583
Feb 20121104155
Mar 20121225262
Apr 2012983746
May 20121164250
Jun 2012703339
Jul 2012935546
Aug 2012663731
Sep 2012996345
Oct 2012783337
Nov 2012853534
Dec 2012773331
Jan 20131112945
Feb 2013782828
Mar 2013693829
Apr 2013742642
May 2013933928
Jun 2013612633
Jul 2013562917
Aug 2013881917
Sep 2013791521
Oct 2013482621
Nov 2013532019
Dec 2013681716
Jan 2014671818
Feb 2014502329
Mar 2014773326
Apr 2014632627
May 2014783537
Jun 2014752022
Jul 2014924828
Aug 2014653431
Sep 2014442722
Oct 2014734344
Nov 2014643728
Dec 2014441923
Jan 2015472417
Feb 2015412721
Mar 2015814524
Apr 2015382618
May 2015392822
Jun 2015304917
Jul 2015372413
Aug 2015651316
Sep 2015624119
Oct 2015281711
Nov 2015202217
Dec 2015692812
Jan 2016532613
Feb 2016703615
Mar 2016411420
Apr 2016702019
May 2016532529
Jun 2016343614
Jul 2016413428
Aug 2016501313
Sep 2016683416
Oct 2016472821
Nov 2016582826
Dec 2016382114
Jan 2017604522
Feb 2017203522
Mar 201782914
Apr 201796518
May 201745927
Jun 2017214913
Jul 201711911719
Aug 201731030917
Sep 20171251169
Oct 2017977923
Nov 2017736514
Dec 201766496
Jan 2018584813
Feb 2018585114
Mar 2018464315
Apr 2018544022
May 2018494115
Jun 2018605320
Jul 2018424215
Aug 2018434116
Sep 2018403211
Oct 201835304
Nov 2018352910
Dec 201827217
Jan 201920149
Feb 2019312411
Mar 2019403417
Apr 2019312917
May 2019342112
Jun 2019221515
Jul 2019252217
Aug 2019453717
Sep 2019261910
Oct 201940345
Nov 2019422316
Dec 2019262511
Jan 2020262414
Feb 2020383027
Mar 2020444016
Apr 2020464032
May 2020242224
Jun 2020424228
Jul 2020685824
Aug 2020252538
Sep 2020474128
Oct 2020564815
Nov 2020453917
Dec 2020716326
Jan 2021555119
Feb 2021373514
Mar 2021504220
Apr 2021363212
May 2021464517
Jun 2021565513
Jul 2021413917
Aug 2021484819
Sep 2021626119
Oct 2021675838
Nov 2021605333
Dec 2021645815
Jan 2022636219
Feb 2022877535
Mar 2022848016
Apr 2022949737
May 202211510529
Jun 202211210829
Jul 2022686522
Aug 202211210931
Sep 202212412036
Oct 202211410825
Nov 20221019210
Dec 2022705812
Jan 2023907714
Feb 202375739
Mar 2023929023
Apr 2023766722
May 2023675518
Jun 202348389
Jul 2023585616
Aug 2023736519
Sep 202337378
Oct 2023605210
Nov 2023102949
Dec 2023987617
Jan 2024181817
Feb 2024665013
Mar 202411411218
Total1065975194287